A004720 Stock Overview
PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PharmGen Science, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,200.00 |
| 52 Week High | ₩7,440.00 |
| 52 Week Low | ₩5,070.00 |
| Beta | 0.55 |
| 1 Month Change | -10.81% |
| 3 Month Change | -12.61% |
| 1 Year Change | -19.38% |
| 3 Year Change | -67.80% |
| 5 Year Change | -33.50% |
| Change since IPO | -54.78% |
Recent News & Updates
Recent updates
PharmGen Science's (KRX:004720) Shareholders Have More To Worry About Than Only Soft Earnings
Mar 27
Is Wooridul Pharmaceutical (KRX:004720) A Risky Investment?
Mar 21Investors Who Bought Wooridul Pharmaceutical (KRX:004720) Shares Five Years Ago Are Now Up 55%
Jan 19Does The Market Have A Low Tolerance For Wooridul Pharmaceutical Limited's (KRX:004720) Mixed Fundamentals?
Dec 21Are Wooridul Pharmaceutical's (KRX:004720) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 25Shareholder Returns
| A004720 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 0% | 5.5% | 3.4% |
| 1Y | -19.4% | 8.1% | 7.1% |
Return vs Industry: A004720 underperformed the KR Pharmaceuticals industry which returned 8.1% over the past year.
Return vs Market: A004720 underperformed the KR Market which returned 7.1% over the past year.
Price Volatility
| A004720 volatility | |
|---|---|
| A004720 Average Weekly Movement | 2.9% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A004720 has not had significant price volatility in the past 3 months.
Volatility Over Time: A004720's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | 250 | Lee Seung-Yeol | www.wooridulpharm.com |
PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It provides prescription drugs, OTC drugs, diagnostic test kits, health and general foods, and cosmetics, as well as shampoo, conditioner, and hair oil products under the neomcell brand name. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc. was founded in 1957 and is headquartered in Hwaseong-si, South Korea.
PharmGen Science, Inc. Fundamentals Summary
| A004720 fundamental statistics | |
|---|---|
| Market cap | ₩94.31b |
| Earnings (TTM) | ₩5.73b |
| Revenue (TTM) | ₩166.78b |
16.5x
P/E Ratio0.6x
P/S RatioIs A004720 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A004720 income statement (TTM) | |
|---|---|
| Revenue | ₩166.78b |
| Cost of Revenue | ₩69.03b |
| Gross Profit | ₩97.75b |
| Other Expenses | ₩92.02b |
| Earnings | ₩5.73b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 315.78 |
| Gross Margin | 58.61% |
| Net Profit Margin | 3.43% |
| Debt/Equity Ratio | 16.2% |
How did A004720 perform over the long term?
See historical performance and comparison